Details of the Drug Formulations

General Information of Drug (ID: DM6W8V5)

• Drug Name: Lisdexamfetamine Drug Info
• Synonyms: NRP104; Lisdexamfetamine (INN); Vyvanse (TN)

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Approved	[1]
Binge eating disorder		Approved	[2]

• Cross-matching ID:
  PubChem CID: 11597698
  ChEBI ID: CHEBI:135925
  CAS Number: 608137-32-2
  TTD ID: D00DEF
  VARIDT ID: DR00003
  INTEDE ID: DR0963
  ACDINA ID: D00369

Full List of Drug Formulations Containing This Drug

Lisdexamfetamine 30 mg capsule

Company	Formulation ID	FDA Description
Physicians Total Care	F12076	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin
Shire	F12077	Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 40 mg capsule

Company	Formulation ID	FDA Description
Physicians Total Care	F12079	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin
Shire	F12080	Fd&c blue no. 1; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 50 mg capsule

Company	Formulation ID	FDA Description
Physicians Total Care	F12083	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin
Shire	F12082	Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 70 mg capsule

Company	Formulation ID	FDA Description
Physicians Total Care	F12086	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Fd&c green no. 3; Gelatin
Avera McKennan Hospital	F12087	Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Gelatin
Shire	F12088	Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 10 mg capsule

Company	Formulation ID	FDA Description
Avera McKennan Hospital	F12070	Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Gelatin
Shire	F12071	Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 20 mg capsule

Company	Formulation ID	FDA Description
Lake Eire Medical & Surgical Supply DBA Quality Care Products	F12073	Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Fd&c red no. 3; Cellulose, microcrystalline; Gelatin
Shire	F12074	Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose

Lisdexamfetamine 10 mg tablet

Company	Formulation ID	FDA Description
Shire	F12069	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 20 mg tablet

Company	Formulation ID	FDA Description
Shire	F12072	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 30 mg tablet

Company	Formulation ID	FDA Description
Shire	F12075	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 40 mg tablet

Company	Formulation ID	FDA Description
Shire	F12078	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 50 mg tablet

Company	Formulation ID	FDA Description
Shire	F12081	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 60 mg tablet

Company	Formulation ID	FDA Description
Shire	F12084	Sucralose; Magnesium stearate; Mannitol; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose

Lisdexamfetamine 60 mg capsule

Company	Formulation ID	FDA Description
Shire	F12085	Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7213).
• [2] Lisdexamfetamine FDA Label